Abstract

A marked decrease in human cancers, including breast cancer, bone cancer, and cervical cancer, has been linked to the consumption of vegetable and fruit, and the corresponding chemoprotective effect has been associated with the presence of several active molecules, such as kaempferol. Kaempferol is a major flavonoid aglycone found in many natural products, such as beans, bee pollen, broccoli, cabbage, capers, cauliflower, chia seeds, chives, cumin, moringa leaves, endive, fennel, and garlic. Kaempferol displays several pharmacological properties, among them antimicrobial, anti-inflammatory, antioxidant, antitumor, cardioprotective, neuroprotective, and antidiabetic activities, and is being applied in cancer chemotherapy. Specifically, kaempferol-rich food has been linked to a decrease in the risk of developing some types of cancers, including skin, liver, and colon. The mechanisms of action include apoptosis, cell cycle arrest at the G2/M phase, downregulation of epithelial-mesenchymal transition (EMT)-related markers, and phosphoinositide 3-kinase/protein kinase B signaling pathways. In this sense, this article reviews data from experimental studies that investigated the links between kaempferol and kaempferol-rich food intake and cancer prevention. Even though growing evidence supports the use of kaempferol for cancer prevention, further preclinical and clinical investigations using kaempferol or kaempferol-rich foods are of pivotal importance before any public health recommendation or formulation using kaempferol.

Highlights

  • Kaempferol represents one of the most encountered aglycone flavonoids in the form of glycoside.It is a tetrahydroxyflavone in which the four hydroxy groups are located at positions 3, 5, 7, and 40, and it is a yellow compound [1]

  • It has been reported that Kaempferol inhibited both growth and migration of glioma cells, even when kaempferol was loaded to mucoadhesive nanoemulsion (KPF-MNE) or kaempferol-loaded nanoemulsion (KPF-NE) [55,56,57]

  • Kaempferol promoted apoptosis, cell cycle arrest at the G2-M phase, and DNA damages [79,80,81,82,83,84], and down-regulated the expression of AKT, ABCB1, BCL2, and ABCC1 genes, protein expression associated with DNA repair system, as well as DNA-dependent serine/threonine protein kinase (DNA-PK), phosphate-ataxia-telangiectasia and Rad3-related (p-ATR), phosphate-ataxia-telangiectasia mutated (p-ATM), 14-3-3 proteins sigma

Read more

Summary

Introduction

Kaempferol represents one of the most encountered aglycone flavonoids in the form of glycoside. Epidemiological studies showed that a high intake of kaempferol is associated with decreased incidence of different types of cancer, among which cancer in organs like skin, liver, colon, ovary, pancreas, stomach, and bladder [6,7]. In this context, kaempferol consumption and related application in cancer therapy are gaining huge attention among the research community [6,7,8]. The inhibition of angiogenesis was reported as well as the capacity of kaempferol to preserve normal cell viability [15]. This review summarizes data on pharmacodynamics, chemopreventive and anticancer effects, and mechanisms of action of kaempferol

Metabolism and Pharmacokinetics of Kaempferol
Antioxidant
Anti-Breast Cancer Activity
Anti-Brain Cancer Activity
Anti-Liver Cancer Activity
Anti-Colon Cancer Activity
Anti-Prostate Cancer Activity
Anti-Pancreatic Cancer Activity
Anti-Blood Cancer Activity
Anti-Lung Cancer Activity
Anti-Kidney Cancer Activity
4.10. Anti-Bladder Cancer Activity
4.11. Anti-Oral Cancer Activity
4.12. Anti-Bone Cancer Activity
4.13. Anti-Cervical Cancer Activity
4.14. Anti-Stomach Cancer Activity
4.15. Anti-Ovarian Cancer Activity
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call